Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 2 , Pages 242-247 , February 2007

Prognostic Factors in Arthrocentesis of the Temporomandibular Joint: Comparison of Bradykinin, Leukotriene B4, Prostaglandin E2, and Substance P Level in Synovial Fluid Between Successful and Unsuccessful Cases

  • Keiseki Kaneyama, DDS, PhD

      Affiliations

    • Lecturer, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa, Japan.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Kaneyama: 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa-Ken, 920-0293 Japan
    • ,
  • Natsuki Segami, DDS, PhD

      Affiliations

    • Professor and Chairman, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa, Japan.
    • ,
  • Jun Sato, DDS, PhD

      Affiliations

    • Lecturer, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa, Japan.
    • ,
  • Kazuma Fujimura, DDS, PhD

      Affiliations

    • Associate Professor, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa, Japan.
    • ,
  • Toshikazu Nagao, DDS, PhD

      Affiliations

    • Assistant Professor, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa, Japan.
    • ,
  • Hiroshi Yoshimura, DDS, PhD

      Affiliations

    • Associate Professor, Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa, Japan.

References 

  1. Nitzan DW, Dolwick MF, Martinez GA. Temporomandibular joint arthrocentesis: A simplified treatment for severe, limited mouth opening. J Oral Maxillofac Surg. 1991;49:1163
  2. Nitzan DW, Samson B, Better H. Long-term outcome of arthrocentesis for sudden-onset, persistent, severe closed lock of the temporomandibular joint. J Oral Maxillofac Surg. 1997;55:151
  3. Nishimura M, Segami N, Kaneyama K, et al. Prognostic factors in arthrocentesis of the temporomandibular joint: Evaluation of 100 patients with internal derangement. J Oral Maxillofac Surg. 2001;59:874
  4. Murakami K, Hosaka H, Moriya Y, et al. Short-term treatment outcome study for the management of temporomandibular joint closed lock (A comparison of arthrocentesis to nonsurgical therapy and arthroscopic lysis and lavage). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:253
  5. Nishimura M, Segami N, Kaneyama K, et al. Comparison of cytokine level in synovial fluid between successful and unsuccessful cases in arthrocentesis of the temporomandibular joint. J Oral Maxillofac Surg. 2004;62:284
  6. Kaneyama K, Segami N, Nishimura M, et al. The ideal lavage volume for removing bradykinin, interleukin-6 and protein from the temporomandibular joint by arthrocentesis. J Oral Maxillofac Surg. 2004;62:657
  7. Quinn JH, Bazan NG. Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg. 1990;48:968
  8. Alstergren P, Kopp S. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg. 2000;58:180
  9. Murakami K, Shibata T, Kubota E, et al. Intra-articular levels of prostaglandin E2, hyaluronic acid, and chondroitin-4 and −6 sulfates in the temporomandibular joint synovial fluid of patients with internal derangement. J Oral Maxillofac Surg. 1998;56:199
  10. Alstergren P, Appelgren A, Appelgren B, et al. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol. 1995;40:127
  11. Holmlund A, Ekblom A, Hansson P, et al. Concentrations of neuropeptides, substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint (A correlation with symptoms, signs and arthroscopic findings). Int J Oral Maxillofac Surg. 1991;20:228
  12. Nishimura M, Segami N, Kaneyama K, et al. Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:328
  13. Sharma JN, Buchanan WW. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol. 1994;46:421
  14. Bond AP, Lemon M, Dieppe PA, et al. Generation of kinins in synovial fluid from patients with arthropathy. Immunopharmacology. 1997;36:209
  15. Rahman MM, Bhoola KD, Elson CJ, et al. Identification and functional importance of plasma kallikrein in the synovial fluid of patients with rheumatoid, psoriatic, and osteoarthritis. Ann Rheum Dis. 1995;54:345
  16. Ishimaru JI, Ogi N, Mizui T, et al. Effects of a single arthrocentesis and a COX-2 inhibitor on disorders of temporomandibular joints (A preliminary clinical study). Br J Oral Maxillofac Surg. 2003;41:323
  17. Davis P, Bailey PJ, Goldenberg MM, et al. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol. 1984;2:335

 This study was partially supported by Grant-in-Aid for Young Scientists (B-16791265) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a Grant for Collaborative Research (C2005-5) from Kanazawa Medical University.

PII: S0278-2391(06)01418-2

doi: 10.1016/j.joms.2005.10.068

Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 2 , Pages 242-247 , February 2007

Article Tools

* Image Usage & Resolution